Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A
- 30 April 1996
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 27 (4) , 519-524
- https://doi.org/10.1016/s0272-6386(96)90162-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranesClinical and Experimental Immunology, 1994
- Platelet-leukocyte aggregation during hemodialysisKidney International, 1994
- The Adequacy of Fragmin as a Single Bolus Dose with Reused DialyzersArtificial Organs, 1994
- Hemostasis in renal disease: Pathophysiology and managementThe American Journal of Medicine, 1994
- Citrate Anticoagulation and Divalent Cations in HemodialysisBlood Purification, 1994
- The Role of Membrane Contact in Hemodialysis-Induced Granulocyte ActivationNephron, 1991
- Reducing the Hemorrhagic Complications of Hemodialysis: A Controlled Comparison of Low-Dose Heparin and Citrate AnticoagulationAmerican Journal of Kidney Diseases, 1987
- Regional Anticoagulation: Hemodialysis With Hypertonic Trisodium CitrateAmerican Journal of Kidney Diseases, 1986
- Hemodialysis Without AnticoagulationAmerican Journal of Kidney Diseases, 1985
- Regional Citrate Anticoagulation for Hemodialysis in the Patient at High Risk for BleedingNew England Journal of Medicine, 1983